Documentos de Dagenais G.R. | REDI

Regresar

Mostrando 2 resultados de: 2

Filtros aplicados

Palabras Claves: "Atrial Fibrillation"

Subtipo de publicación

Publisher

Cardiovascular Research(1)

Diabetes, Obesity and Metabolism(1)

Área temáticas

Enfermedades(2)

Anatomía humana, citología, histología(1)

Farmacología y terapéutica(1)

Medicina y salud(1)

Problemas sociales y servicios a grupos(1)

Área de conocimiento

Enfermedad cardiovascular(1)

Medicina interna(1)

Año de Publicación

Origen

Palabras Claves

Type 2 Diabetes(1)

atrial flutter(1)

epidemiology(1)

Global variations in the prevalence, treatment, and impact of atrial fibrillation in a multi-national cohort of 153 152 middle-aged individuals

Abstract: Aims: To compare the prevalence of electrocardiogram (ECG)-documented atrial fibrillation (or flutte

Palabras claves:

Atrial Fibrillation, CLSA, epidemiology

Alhabib K.F., Avezum A.J., Bahonar A., Chifamba J., Connolly S.J., Dagenais G.R., Dans A.M., Douma R., Gupta R., Healey J.S., Huisman H., Ibrahim Q., Islam S., Ismail R., Iype T., Joseph P.G., Kazmi K., Kengne A.P., Keskinler M.V., Kumar R., Lanas F.T., Lear S.A., Mohan V., Mony P.K., Orlandini A., PATRICIO LOPEZ -JARAMILLO, Rahman O., Raina P., Rangarajan S., Rosengren A., Teo K.K., Wei L., Yeates K.E., Yusuf S., Yusufali A.M., Zatońska K.

Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the REWIND randomized trial

Abstract: Aim: To assess the occurrence of atrial fibrillation or atrial flutter (atrial arrhythmias [AA]) in

Palabras claves:

Atrial Fibrillation, atrial flutter, dulaglutide, glucagon-like peptide-1 receptor agonists, Type 2 Diabetes

Avezum A.J., Basile J.N., C. Gerstein H., Conget I., Cushman W.C., Dagenais G.R., Hoover A., Jansky P., Lanas F.T., Leiter L.A., PATRICIO LOPEZ -JARAMILLO, Pogosova N., Probstfield J.L., Rao-Melacini P., Raubenheimer P.J., Rydén L.E., Sheu W.H.H., Temelkova-Kurktschiev T.